
CSL Behring Rolls Out 10g Prefilled Syringe for Patients with Primary Immunodeficiency, CIDP
KING OF PRUSSIA, PA — CSL Behring, the biotechnology unit of CSL Limited, recently unveiled a 10g prefilled syringe for Hizentra, its treatment for Primary Immunodeficiency (PI) and Chronic Inflammatory …
CSL Behring Rolls Out 10g Prefilled Syringe for Patients with Primary Immunodeficiency, CIDP Read More